Abstract
Purpose
Spectral domain optical coherence tomography (SD OCT) may be useful for efficient measurement of drusen in patients with age-related macular degeneration (AMD). We evaluated areas identified as drusen from semi-automated segmentation of drusen on SD OCT versus those identified from review of digital color fundus photographs (CFP).
Methods
Twelve eyes with non-neovascular AMD were prospectively imaged with digital CFP and SD OCT. For each eye, areas on CFP in which at least 2 of 3 retina specialists agreed upon drusen presence produced the composite CFP drusen map. Automated image analysis produced another CFP map. Areas identified as drusen by segmentation on SD OCT B-scans were plotted as the SD OCT drusen map. The CFP and SD OCT maps were compared and agreement was quantified. Disagreement was characterized into distinct types and the frequency of each type was quantified.
Results
There was general agreement between CFP and SD OCT in identifying presence and absence of drusen, with mean agreement in 82±9% of total image pixels. Most disagreement (80±15%) occurred at drusen margins. There was a trend for greater detection of drusen with SD OCT in eyes with larger drusen and with hyperpigmentation. There was a trend for greater detection of smaller drusen by CFP.
Conclusions
We demonstrate good agreement in drusen detection between CFP and SD OCT. Areas of disagreement underscore limitations of CFP-based measurement of drusen, particularly in the sizing of large, soft drusen. SD OCT shows great promise as an adjunctive tool for assessing drusen burden in AMD.
Efficient phenotyping of non-neovascular age-related macular degeneration (AMD) is an increasing priority as clinical management of the disease evolves. Drusen are a defining feature of AMD, and numerous longitudinal studies have demonstrated positive correlations between estimated total drusen area and maximum drusen size with risk of progression to advanced AMD.1–5 These parameters are now commonly used in establishing entry criteria and endpoints for disease progression in clinical trials.1–4
Presently, evaluation of color fundus photographs (CFPs) represents the gold standard for drusen measurement in non-neovascular AMD. Total drusen area and maximum drusen size are estimated by visual inspection of drusen in CFPs, with comparison to a set of standardized circles.6–8 However, it can be challenging to reliably localize drusen against the varying background of the pigments of the macula, retinal pigment epithelium (RPE), and choroid.6, 9, 10 Furthermore, while reduction of drusen properties into categorical data increases the efficiency of manual CFP grading and statistical analysis, it may be an oversimplification in the evaluation of drusen burden.
Optical coherence tomography (OCT) provides in vivo imaging of drusen in cross section. Recent spectral domain OCT systems (SD OCT), with their increase in imaging speed over conventional OCT, obtain over one hundred high-resolution scans in the time required to capture less than 10 time-domain scans.11–14 Thus, SD OCT represents a promising alternative modality for imaging drusen. Khanifar et al. demonstrated that SD OCT provides novel information regarding drusen ultrastructure in vivo.15 Schuman et al. detected and quantified decreased photoreceptor layer (PRL) thickness over drusen as seen in SD OCT images of AMD patients.16 Furthermore, using a summed-voxel-projection17 (SVP) of a series of B-scans of the posterior pole, an en face representation of SD OCT reflectivity can be registered to CFPs to provide an area map of drusen segmented on OCT (Figure 1).18 In a proof of concept, Yi et al. used SD OCT to quantify drusen area and volume in a patient with non-neovascular AMD.19
Currently, there is no comparative study as to how sites identified as drusen with SD OCT relate to the size and area of lesions identified as drusen on CFP. It will be important to understand this relationship if drusen measurement from SD OCT analysis will be used in future studies. The purpose of this study is to compare areas designated as drusen from SD OCT images to those designated as drusen on CFPs in the maculas of patients with high-risk non-neovascular AMD. We perform a quantitative comparison of total drusen area and maximum drusen size identified with the two modalities. We hypothesize that drusen extent determined with SD OCT correlate with findings on CFP. Differences between the two are explored.
Materials and Methods
Data Collection
All subjects provided informed consent to participate in the Age Related Eye Disease Study (AREDS) 2 and the AREDS2 Ancillary SD OCT Study. For inclusion in the study, subjects had a clinical diagnosis of AREDS Category 3 non-neovascular AMD. This study was approved by the Duke University Health System Institutional Review Board, and the study protocol followed the tenets set forth in the Declaration of Helsinki. The enrollment period for this pilot study extended from March 27, 2007 to February 21, 2008.
Twelve eyes from twelve patients with AREDS Category 3 AMD were prospectively imaged with non-stereoscopic digital CFP (Zeiss 450; Carl Zeiss Meditec Inc., Dublin, CA) and with SD OCT (Bioptigen Inc., Research Triangle Park, NC). Each SD OCT image set was acquired over a 6.6mm by 6.6mm area with 100 B-scans obtained in approximately 5 seconds. Each B-scan consisted of 1000 A-scans, with a 66μm interval between consecutive B-scans. For each set of 100 B-scans, the volume was averaged axially to produce a [100×1000] pixels SVP retinal image (Figure 1).17 Calibration of pixel size is based on 6.6mm by 6.6mm scanning protocol used by the FDA-approved Bioptigen SD OCT unit. The eyes in this study were not profoundly hyperopic or myopic.
Drusen Grading Protocols
Three retina specialists at Duke University independently marked all areas they considered as drusen on each digital CFP using the Pencil tool in Adobe Photoshop (Adobe Systems Inc, San Jose, CA). Analysis was confined to a macular area of approximately 2mm in diameter, centered on the fovea. A “composite CFP” drusen map was then created by identifying all areas in which at least 2 of 3 graders agreed upon the presence of drusen (Figure 2). Unless otherwise stated, the composite CFP map is used to represent the CFP drusen markings for comparative analysis in this study.
In addition to manual segmentation, we used software to detect and segment drusen area on CFP images in an automated fashion.20 This software was developed and implemented by the Columbia University team without knowledge of the drusen identification rules or results from the manual grading at Duke University. The automated approach utilized a detailed mathematical model based on the geometry of fundus reflectance reconstructed individually for each image to correct macular background and illumination variability.21 Highly reflectant structures, such as nerve fiber layer bundles at the arcades, retinal pigment epithelium (RPE) hypopigmentation, and exudates, are more frequently mistaken for drusen by an automated method than by an expert grader, requiring post-processing steps. Consequently, we developed a more efficient user-interactive method, in which the user initially selects areas of interest from drusen images, excluding unwanted reflectant structures a priori. The algorithm then computes the background model and final drusen segmentation of the macula, recognizing the absence of drusen beyond the ROI (Figure 3). This method permits the capture of even low contrast lesions by uniform thresholds and has been validated and utilized to quantify the relationship between drusen, autofluorescence (AF), and AMD disease progression.21–23 All algorithms were implemented in a graphical user interface (GUI) written and compiled in MATLAB (The MathWorks Inc, Natick, MA) as a free-standing executable.
Automated drusen segmentation for the SD OCT images was performed using the Duke OCT Retinal Analysis Program (DOCTRAP).24 The DOCTRAP algorithm detects and segments retinal layers such as the retinal nerve fiber layer (RNFL) inner boundary and the RPE using a modified implementation of the deformable contours method.25 DOCTRAP software identifies suspect drusen areas based on irregularities in the RPE contour. An expert SD OCT reader refined drusen segmentation on each B-scan in the study.
Several manual adjustments were made to the DOCTRAP drusen segmentation, including a) adjustment of the lateral extent of marked drusen to correspond to the point at which the RPE deflection returned to baseline; b) manual delineation of drusen not identified by DOCTRAP software because of a minimal or atypical distortion of the RPE layer; and c) removal of zones of improper segmentation in which drusen were falsely identified by DOCTRAP software. Manual refinement was performed in approximately 10 minutes for each set of 100 B-scans. This step on average accounted for an alteration in grading of 4±3% of total pixels in the central macular area on the SD OCT drusen map.
To grade drusen size, the Photoshop Measure tool was used to manually measure the diameter of the largest druse present (Figure 4). This was performed on both the composite CFP and SD OCT drusen maps. In the case of confluent drusen, the maximum linear span of contiguous drusen was measured.
Image Interpolation and Registration
Because of the limited SD OCT B-scan sampling in the azimuthal direction (Figure 1), interpolation of the SD OCT drusen markings was performed to estimate drusen extent between consecutive B-scans. That is, to match the size of the CFP images, SVP retinal images were interpolated to contain [1000×1000] pixels.
We implemented two interpolation techniques (Figure 2). We initially used the MATLAB 2-D data interpolation function (“interp2” function with “cubic” parameter). Due to the asymmetric resolution enhancement factors (factor of 10 in the azimuthal and 1 in the lateral direction), this function in effect simplified to a 1-D interpolation in the azimuthal direction, resulting in stepwise sharp discontinuities in the interpolated SD OCT drusen map. As an alternative approach to acquire a smoother reconstruction, we used the 2-D Nadaraya–Watson estimator (NWE) with a Gaussian kernel of size [21×21] and variance of 6 pixels.26 These interpolated images were thresholded to create binary drusen maps. For each individual image, we adaptively selected the threshold so that the ratio of drusen versus non-drusen area would be equal in the interpolated and non-interpolated SVP images (of size [1000×1000] and [100×1000] pixels, respectively). Unless otherwise stated, this SD OCT drusen map with the NWE interpolation is used to represent the SD OCT drusen markings for comparative analysis in this study.
Retinal images were imported into Photoshop and co-registered manually by adjustment of the CFP with respect to the SVP using the Free Transform tool. Using this function, we translated, rotated, scaled, and skewed the CFP image to closely register these images. As our main goal was to register the central macular area, which occupies approximately 7% of the total image area, particular attention was paid to ensure proper alignment of all vascular features which immediately surround this area. We noted that, even if such rigid warping transforms do not perfectly represent the global warping between these two images, they efficiently approximate the local warping transform in this small central region. Several co-authors (NJ, SF, AAK, CAT) inspected each image set to confirm that the co-registration was robust.
Analysis Protocol
Intergrader agreement for the three separate manual gradings of the CFPs was assessed at the level of individual pixels. Pairs of the CFP grading masks were overlaid in Photoshop and subtracted to localize areas of agreement and disagreement in drusen identification. Pixel counts for agreement and disagreement were quantified using MATLAB. In similar fashion, agreement and disagreement were computed for the two primary measurement techniques: the composite (agreement by any 2 of 3 graders) CFP drusen map versus the SD OCT drusen map.
Areas of disagreement in drusen identification between the composite CFP map and the SD OCT drusen map were evaluated to identify the most frequent types of disagreement. Four broad categories of disagreement were assessed, based on simultaneous inspection of the CFP and corresponding SD OCT B-scans: I, disagreement at margins just outside of areas in which both modalities agree “yes” for drusen; II, hypopigmentation on CFP without a corresponding finding on SD OCT; III, pigment migration with obscuration of underlying drusen on CFP; and IV, drusen shaped lesions on OCT without a corresponding finding on CFP. Each pixel of disagreement was assigned to a specific category, and manually marked with a labeling color. This analysis was performed by one grader (NJ), and all areas of marking were reviewed with agreement by a second grader (CAT). The color-coded image of disagreement was then imported into MATLAB, and the relative frequency of each type of disagreement was quantified.
Statistical Methods
The mean and standard deviation of the total area identified as drusen is reported for each grading modality. Similar data are presented for each type of disagreement, as a percentage of total disagreement. An intraclass correlation coefficient (ICC) is computed using SAS statistical software (SAS Institute, Cary, NC) for pairs of grading modalities. A paired Student's t-test is used to compare drusen size measurements between modalities. A Bland-Altman plot for drusen area is reported for the two primary drusen maps: the composite CFP map and the SD OCT (with NWE interpolation) map.27
Results
Drusen Extent
We quantified and compared drusen area with CFP- and SD OCT-based measurement for 12 subjects. The area of drusen ranged from 0.2mm2 to 3.0mm2 by SD OCT (7% to 97% of the central macular area); 0.5mm2 to 3.1mm2 by composite CFP (16% to 99.5%); and 0.5mm2 to 2.7mm2 by automated segmentation of drusen on CFP (16% to 88%). Mean drusen area was 1.3±0.9mm2 by SD OCT, 1.2±0.8mm2 by composite CFP, and 1.2±0.8mm2 by automated segmentation of CFP (Table 1). There was a trend for SD OCT-based grading to identify a greater area of drusen as the total drusen area increased (Figure 5). The intraclass correlation coefficient for drusen area between SD OCT and composite CFP was 0.94 (95% CI 0.81, 0.98) (Figure 6). In contrast, the mean intraclass correlation coefficient for comparison amongst the three independent CFP graders was 0.90±0.05.
Table 1.
SD OCT |
CFP |
|||||||
---|---|---|---|---|---|---|---|---|
2D Interpolation | NWE Interpolation | Automated | Composite | Grader 1 | Grader 2 | Grader 3 | ||
Eye | mm2 | (%) | mm2 | mm2 | mm2 | mm2 | mm2 | mm2 |
1 | 0.3 | (9) | 0.2 | 0.5 | 0.5 | 0.6 | 0.5 | 0.5 |
2 | 0.6 | (19) | 0.6 | 0.8 | 0.8 | 0.9 | 0.9 | 1.0 |
3 | 0.6 | (19) | 0.6 | 0.6 | 0.6 | 0.4 | 0.6 | 0.7 |
4 | 0.7 | (22) | 0.7 | 0.6 | 0.6 | 0.8 | 0.6 | 0.7 |
5 | 0.7 | (23) | 0.7 | 0.9 | 1.0 | 1.0 | 1.0 | 1.0 |
6 | 0.9 | (29) | 0.9 | 0.7 | 0.8 | 1.0 | 0.7 | 1.1 |
7 | 1.0 | (32) | 1.0 | 0.7 | 0.9 | 1.4 | 0.9 | 0.7 |
8 | 1.2 | (39) | 1.2 | 0.9 | 1.1 | 0.9 | 1.2 | 1.3 |
9 | 1.8 | (58) | 1.9 | 1.6 | 1.4 | 1.6 | 1.2 | 1.4 |
10 | 2.3 | (75) | 2.4 | 1.9 | 2.0 | 2.0 | 2.0 | 1.9 |
11 | 2.3 | (73) | 2.4 | 2.3 | 1.8 | 1.9 | 1.7 | 1.9 |
12 | 3.0 | (95) | 3.0 | 2.7 | 3.1 | 3.1 | 2.2 | 3.1 |
| ||||||||
Mean | 1.3 | (41) | 1.3 | 1.2 | 1.2 | 1.3 | 1.1 | 1.3 |
| ||||||||
SD | 0.9 | (28) | 0.9 | 0.8 | 0.8 | 0.8 | 0.6 | 0.7 |
Across this wide range of drusen size and area, grading by SD OCT and composite CFP on average agreed in classification of 82±9% of pixels. Another 10±8% of pixels were determined to be drusen with SD OCT and not composite CFP, and 8.0±4% were determined to be drusen with composite CFP and not SD OCT (Figure 7). Of the total area across all eyes identified as drusen with composite CFP, 80% of pixels were also identified as drusen with SD OCT. In comparison, of the total area identified as drusen with SD OCT, 75% of pixels were also identified as drusen with composite CFP. The relative agreement between markings on SD OCT versus CFP was similar to the intergrader agreement in delineating drusen on CFP, which had a mean agreement of 82±6% of total image area.
The greatest linear span of a contiguous druse was consistently greater with SD OCT than with composite CFP. The mean size of the largest druse by SD OCT was 1286±555μm; the mean size of the largest druse by composite CFP was 915±501μm (Table 2). The mean difference was 371μm (p = 0.008).
Table 2.
Eye | SD OCT Max Length [μm) | CFP Max Length [μm) | Difference (SD OCT-CFP) (μm) |
---|---|---|---|
1 | 330 | 340 | −10 |
2 | 690 | 600 | 90 |
3 | 900 | 690 | 210 |
4 | 1000 | 690 | 310 |
5 | 1010 | 700 | 310 |
6 | 1160 | 520 | 640 |
7 | 1220 | 830 | 390 |
8 | 1300 | 1240 | 60 |
9 | 1880 | 670 | 1210 |
10 | 1980 | 1760 | 220 |
11 | 1980 | 960 | 1020 |
12 | 1980 | 1980 | 0 |
| |||
Mean | 1286 | 915 | 371 (p=0.008) |
| |||
SD | 555 | 501 | 395 |
Interpolation Results
Segmentation of drusen on OCT demonstrated a mean drusen area of 1.3±0.9mm2 for both the NWE interpolation and the MATLAB 2-D interpolation. Varying interpolation strategy of the SD OCT drusen markings led to a change in 5±2% of total pixels. Both strategies resulted in a similar level of agreement when compared to the drusen markings on the composite CFP map (82% agreement for NWE vs. 81% agreement for the MATLAB 2-D interpolation).
Disagreement Types
Areas of disagreement in marking of drusen with SD OCT versus composite CFP were grouped into four distinct types (Figures 8, 9). The majority of disagreement occurred at the margins just outside of areas in which both modalities agreed “yes” for drusen (Table 3). This broad category of disagreement (Type I) occurred in each of the 12 eyes, and accounted for 80±15% of all pixels with disagreement. In these area with Type I disagreement, the CFP and corresponding SD OCT scans were inspected to provide an estimate of the true extent of the drusen. Based on this estimate, it was determined that in each instance, either the CFP grading had undermarked drusen (disagreement subtype IA, royal blue), the SD OCT grading had undermarked drusen (disagreement subtype IB, light blue), or that it was indeterminate which of the two modalities represented the true extent of drusen (disagreement subtype IC, orange). A scatter plot of area of disagreement attributed to subtypes IA and IB against total drusen area shows inverse trends for these two important types of disagreement in marking drusen borders (Figure 10).
Table 3.
Color | Type | Description of Disagreement Type | Number of Eyes | Mean % of Disagreement |
---|---|---|---|---|
IA | Undermarking of drusen borders by CFP | 12 | 35 ± 21 | |
IB | Undermarking of drusen borders by SD OCT | 12 | 27 ± 14 | |
IC | Nonspecific disagreement at drusen borders | 12 | 18 ± 13 | |
II | Hypopigmentation on CFP without SD OCT finding | 11 | 10 ± 10 | |
III | Pigmentary migration with obscuration of underlying druse | 5 | 6 ± 9 | |
IV | SD OCT deflection without corresponding pigmentary change | 9 | 5 ± 5 |
Another type of disagreement (Type II, light green) consisted of small areas of hypopigmentation identified as drusen on CFP, but with no corresponding finding on SD OCT. These “drusen” had a maximum diameter of 220μm, with a median diameter of approximately 70μm. This type of disagreement occurred in 11 of 12 eyes, and accounted for 10±10% of total disagreement by area.
There were two different findings at the sites of Type II disagreement. In the majority of such instances (73 of 99), the lesions were greater than 60μm in diameter, appeared to have an SD OCT scan across the location, with minimal to no disturbance of the RPE contour on the B-scan. In the remaining 26 of 99 such instances, we suspect that drusen were undetected on SD OCT because of the unsampled space (approximately 40μm, presuming a 15μm wide diameter site sampled by the SD OCT beam at the retina) between adjacent B-scans. In these cases, inspection of other SD OCT scans of the same eye at greater resolution can visibly demonstrate a subtle deflection of RPE in the area corresponding to the lesion on the CFP.
A third type of disagreement (Type III, dark green), occurred at regions where pigment migration or hyperpigmentation masked the presence of drusen on the CFP. SD OCT scans documented the extent of drusen material (often large confluent drusen) beneath hyperreflective zones corresponding to the site where drusen were not marked on CFP. This type of disagreement accounted for a mean of 6±9% of total disagreement, and occurred only in the 5 eyes with such pigmentary changes. However, in these eyes, this type of disagreement accounted for a mean of 13±9% of total disagreement, and as much as 24% of the total disagreement. In one subject, not only did hyperpigmentation obscure 16% of the total drusen area, but outside the central macular area, a large area of hypopigmentation masqueraded as a large druse (Figure 11). In these instances, drusen measurement with SD OCT appeared to be more accurate than with CFP.
A fourth type of disagreement (Type IV, yellow) consisted of areas clearly demonstrating drusen on the SD OCT B-scan without a visible appearance of drusen on CFP. To contrast with Type III disagreement, in these instances there was no associated hyperpigmentation to account for the masking of drusen on CFP. This disagreement type occurred in 9 of 12 eyes, accounting for 5±5% of total disagreement.
Discussion
SD OCT is a novel imaging modality for quantifying drusen size and area in patients with AMD. The high resolution and limited motion artifact in SD OCT scans makes possible a precise characterization of drusen extent with sequential scanning across the macula. In this study, we validate the accuracy of this technique by comparison to the prevailing standard of CFP-based drusen measurement.
We report the first quantitative comparison of drusen area measurement by SD OCT versus CFP. Our findings corroborate our hypothesis that drusen area as determined with SD OCT will be similar to area determined with CFP. Interestingly, drusen grading with SD OCT appears to have increased sensitivity in subjects with greater total drusen burden, as is depicted in the Bland-Altman plot (Figure 5).
Comparison of disagreement between SD OCT-based versus CFP-based marking of drusen at the level of individual pixels is highly informative. Most lesions that are classically interpreted as drusen on CFP have corresponding findings on SD OCT, and vice versa. The predominant type (Type I) of disagreement occurs at the boundaries of regions identified as drusen by both modalities. This disagreement type accounted for 80±15% of total disagreement between the two modalities, and also accounts for the notable disagreement in largest drusen size between the two modalities.
The difficulty in precisely identifying the borders of drusen represents an important challenge. A high degree of precision is required if we strive to use either CFP or SD OCT as a tool to monitor disease longitudinally. We argue that SD OCT offers greater precision for patients with advanced disease. Cross-sectional images of drusen at the axial resolution offered by SD OCT and with the sampling density selected for this study provide much greater detail regarding borders of large, soft drusen than can be extracted from inspection of CFPs. In contrast, for tiny and sharply delineated small “hard” drusen, CFP offers an advantage in imaging over SD OCT scanning at 66μm intervals. Precise characterization of higher risk large drusen is likely to be more valuable in the clinical setting.
This strength of SD OCT is supported by quantitative data from our study. In subjects with greatest drusen burden, in whom drusen merge to form large confluent lesions, there was an increasing proportion of Type IA disagreement (undermarking of drusen borders by CFP) (Figure 10). Type IA disagreement represents the subtype with greatest contribution to overall disagreement between the two modalities (35±21% of total disagreement). This disagreement subtype is also largely responsible for the difference in maximum drusen size, where measurements on SD OCT are consistently greater than those on CFP (Table 2).
Disagreement Type II, representing sites of hypopigmentation on CFP without a corresponding finding on OCT, encompasses a group of relatively small lesions. In the majority of cases, it is indeterminate whether or not these lesions represent true drusen versus nonspecific hypopigmentation. This again underscores limitations in CFP-based grading of drusen, which relies heavily on macular pigmentary changes as a sign of drusen presence, despite the increased frequency of pigmentary changes such as RPE atrophy, hyperplasia, and migration in AMD.
In a minority of cases, we suspect that sites with Type II disagreement represent true drusen that are undetected with SD OCT because of the spacing between adjacent B-scans in our imaging protocol. Greater sampling density has been shown to increase detection of small drusen (unpublished data, Sina Farsiu, 2008). For this study population with AREDS Category 3 AMD, as shown by our quantitative analysis, this sampling frequency did not introduce substantial disagreement between SD OCT- and CFP-based grading of drusen. The issue of undersampling may be more significant if SD OCT were used in the assessment of drusen burden in early AMD. Further study of SD OCT with greater B-scan sampling would clarify the utility of this imaging modality in patients with early AMD.
Type III and Type IV disagreement also result from the overreliance of CFP-based grading on pigmentary changes for drusen identification. Type III disagreement accounts for instances in which drusen were concealed by overlying pigmentary changes. In Type IV disagreement, lesions with clear drusenoid RPE deflection on OCT did not produce a corresponding pigmentary change that was recognized as drusen on CFP.
The ultimate goal for SD OCT-based drusen measurement would be to have fully automated segmentation of drusen on OCT. In this study, we performed semiautomated segmentation to evaluate the optimal performance of SD OCT in quantifying drusen. The intent was to avoid major segmentation errors that would significantly sway the results. Refinement of automated segmentation on SD OCT B-scans was performed rapidly, and had surprisingly little effect on ultimate drusen area measurements. A total of 4±3% of pixels was altered by manual refinement of SD OCT drusen markings.
In completing the SD OCT-based measurement of drusen area, we used the NWE interpolation strategy to up-sample our 100 linear B-scans to span the 1000 pixels vertically across the macula. This interpolation strategy was chosen to model the natural tendency of drusen to have curvilinear borders. We also performed the analysis using a more simplistic MATLAB 2D interpolation to examine the influence of interpolation strategy on the results. Our analysis demonstrated that although visually appearing to have greater agreement, the NWE interpolation strategy had only a minor influence of on ultimate agreement with CFP drusen markings.
A potential challenge in this type of study is that there is no gold standard for measurement of drusen area. Aware of this limitation, we used statistical methods that do not rely on the comparison to a gold standard. Furthermore, we chose to use a `composite CFP' drusen map, defining drusen and non-drusen areas as sites where any two of three graders agreed, to minimize the potential bias introduced by any one grader. When checking this composite grading to a previously published method of automated segmentation of drusen on CFP,21 the findings were remarkably similar.
One limitation of this pilot study is the small sample size. However, the 12 subjects in the study represented a broad sampling of AREDS Category 3 AMD phenotypes. A variety of different drusen morphologies and sizes were present. Drusen area ranged from 7% to 97% of our central macular area by SD OCT. A further limitation is that accurate comparison between two different imaging modalities at the level of individual pixels requires accurate co-registration of the CFP and SVP retinal image. Fortunately, the SVP retinal image offers many landmarks in the form of vessel shadows to properly co-register the images. To maximize agreement between images, rather than using automated image registration techniques, we co-registered all images manually. Inaccuracies in image co-registration, however small, would reduce the overall level of agreement in drusen identification between the two modalities.
This study provides a comparison of SD OCT- and CFP-based drusen measurement at a single time point, and does not provide longitudinal data. Additionally, we do not perform drusen volume measurements in this study, as this information cannot be quantified in CFP analysis. The capacity for SD OCT to provide volume measurements is a unique feature of this imaging modality that we are actively studying.
Combined analysis of both the qualitative characteristics of drusen15 and quantitative measurements from SD OCT imaging of the macula in AMD is very likely to result in improved characterization of the AMD phenotype. For example, the AREDS severity scale combines both qualitative and quantitative drusen characteristics in a stepwise scale that correlates with greater risk of progression to advanced disease.2 Klein et al. have shown patterns of drusen or pigment on CFP that are likely to precede geographic atrophy.28 The utility of SD OCT analysis to precisely identify disease stage and predict risk of future progression to advanced disease and vision impairment remains to be demonstrated in a longitudinal study. These questions will be examined in the longitudinal 5-year Age-Related Eye Disease Study 2 Ancillary SDOCT Study (http://clinicaltrials.gov/ct2/show/NCT00734487, viewed October 16, 2009).
Drusen area and size measurements are unmistakably correlated with disease progression in non-neovascular AMD. Advances in the management of AMD demand a level of precision in both clinical trials and the clinical setting that is not possible with color photography alone. This pilot study shows that SD OCT can be an important tool in measuring drusen extent, and offers the potential for greater precision and efficiency than CFP alone.
Acknowledgements
The authors thank Dr. Sandra Stinnett for assistance with statistical analysis and the Age Related Eye Disease Study 2 for its support.
This project, from the Duke Advanced Research in SDOCT Imaging (DARSI) Laboratory, was supported in part by: Alcon Laboratories, the National Institutes of Health R21 EY017393, the National Institutes of Health K23 EY018895, Genentech, and The North Carolina Biotechnology Center Collaborative Funding Grant #2007-CFG-8005 with Bioptigen.
Dr. Khanifar serves as a consultant for iCo Therapeutics. Dr. Bearelly receives research support from the NIH. Dr. Izatt serves as Chairman and Chief Technology Officer for Bioptigen. Dr. Toth receives royalties from Alcon Laboratories (honoraria and license agreement), and has other research funding from Sirion Therapeutics, NIH, and Genentech.
References
- 1.Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology. 2002;109:1767–1779. doi: 10.1016/s0161-6420(02)01146-6. [DOI] [PubMed] [Google Scholar]
- 2.Davis MD, Gangnon RE, Lee LY, et al. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123:1484–1498. doi: 10.1001/archopht.123.11.1484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Wang JJ, Foran S, Smith W, Mitchell P. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol. 2003;121:658–663. doi: 10.1001/archopht.121.5.658. [DOI] [PubMed] [Google Scholar]
- 4.van Leeuwen R, Klaver CC, Vingerling JR, Hofman A, de Jong PT. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol. 2003;121:519–526. doi: 10.1001/archopht.121.4.519. [DOI] [PubMed] [Google Scholar]
- 5.Bressler SB, Maguire MG, Bressler NM, Fine SL. Relationship of drusen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. The Macular Photocoagulation Study Group. Arch Ophthalmol. 1990;108:1442–1447. doi: 10.1001/archopht.1990.01070120090035. [DOI] [PubMed] [Google Scholar]
- 6.Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128–1134. doi: 10.1016/s0161-6420(91)32186-9. [DOI] [PubMed] [Google Scholar]
- 7.The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the Age-Related Eye Disease Study Report Number 6. Am J Ophthalmol. 2001;132:668–681. doi: 10.1016/s0002-9394(01)01218-1. [DOI] [PubMed] [Google Scholar]
- 8.Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–374. doi: 10.1016/s0039-6257(05)80092-x. [DOI] [PubMed] [Google Scholar]
- 9.Smith RT, Chan JK, Nagasaki T, Sparrow JR, Barbazetto I. A method of drusen measurement based on reconstruction of fundus background reflectance. Br J Ophthalmol. 2005;89:87–91. doi: 10.1136/bjo.2004.042937. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Shin DS, Javornik NB, Berger JW. Computer-assisted, interactive fundus image processing for macular drusen quantitation. Ophthalmology. 1999;106:1119–1125. doi: 10.1016/S0161-6420(99)90257-9. [DOI] [PubMed] [Google Scholar]
- 11.Drexler W, Sattmann H, Hermann B, et al. Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol. 2003;121:695–706. doi: 10.1001/archopht.121.5.695. [DOI] [PubMed] [Google Scholar]
- 12.Wojtkowski M, Srinivasan V, Fujimoto JG, et al. Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2005;112:1734–1746. doi: 10.1016/j.ophtha.2005.05.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Srinivasan VJ, Wojtkowski M, Witkin AJ, et al. High-definition and 3-dimensional imaging of macular pathologies with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2006;113:2054 e2051–2014. doi: 10.1016/j.ophtha.2006.05.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Pieroni CG, Witkin AJ, Ko TH, et al. Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration. Br J Ophthalmol. 2006;90:191–197. doi: 10.1136/bjo.2005.076612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Khanifar AA, Koreishi AF, Izatt JA, Toth CA. Drusen ultrastructure imaging with spectral domain optical coherence tomography in age-related macular degeneration. Ophthalmology. 2008;115:1883–1890. doi: 10.1016/j.ophtha.2008.04.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Schuman S, Koreishi A, Farsiu S, Jung S, Izatt J, Toth C. Photoreceptor Layer Thinning over Drusen in Eyes with Age-Related Macular Degeneration Imaged In Vivo with Spectral-Domain Optical Coherence Tomography. Ophthalmology. 2009;116:488–496. doi: 10.1016/j.ophtha.2008.10.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Jiao S, Knighton R, Huang X, Gregori G, Puliafito C. Simultaneous acquisition of sectional and fundus ophthalmic images with spectral-domain optical coherence tomography. Opt Express. 2005;13:444–452. doi: 10.1364/opex.13.000444. [DOI] [PubMed] [Google Scholar]
- 18.Stopa M, Bower BA, Davies E, Izatt JA, Toth CA. Correlation of pathologic features in spectral domain optical coherence tomography with conventional retinal studies. Retina. 2008;28:298–308. doi: 10.1097/IAE.0b013e3181567798. [DOI] [PubMed] [Google Scholar]
- 19.Yi K, Mujat M, Park BH, et al. Spectral domain optical coherence tomography for quantitative evaluation of drusen and associated structural changes in non-neovascular age-related macular degeneration. Br J Ophthalmol. 2009;93:176–181. doi: 10.1136/bjo.2008.137356. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Smith RT, Noah L, Jian C, Busuioc M, Laine AF. Interactive image analysis in age-related macular degeneration (AMD) and Stargardt disease (STGD). 42nd Asilomar Conference: Signals, Systems and Computers; 2008. pp. 651–654. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Smith RT, Chan JK, Nagasaki T, et al. Automated detection of macular drusen using geometric background leveling and threshold selection. Arch Ophthalmol. 2005;123:200–206. doi: 10.1001/archopht.123.2.200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hwang JC, Chan JW, Chang S, Smith RT. Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:2655–2661. doi: 10.1167/iovs.05-1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Smith RT, Chan JK, Busuoic M, Sivagnanavel V, Bird AC, Chong NV. Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2006;47:5495–5504. doi: 10.1167/iovs.05-1318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Farsiu S, Chiu SJ, Izatt JA, Toth CA. Photonics West, Ophthalmic Technologies. San Jose, CA: 2008. Fast detection and segmentation of drusen in retinal optical coherence tomography images; pp. 68440D–68441.pp. 68412 [Google Scholar]
- 25.Xu C, Prince JL. Snakes, shapes, and gradient vector flow. Image Processing, IEEE Transactions on. 1998;7:359–369. doi: 10.1109/83.661186. [DOI] [PubMed] [Google Scholar]
- 26.Takeda H, Farsiu S, Milanfar P. Kernel Regression for Image Processing and Reconstruction. Image Processing, IEEE Transactions on. 2007;16:349–366. doi: 10.1109/tip.2006.888330. [DOI] [PubMed] [Google Scholar]
- 27.Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8:135–160. doi: 10.1177/096228029900800204. [DOI] [PubMed] [Google Scholar]
- 28.Klein ML, Ferris FL, 3rd, Armstrong J, et al. Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology. 2008;115:1026–1031. doi: 10.1016/j.ophtha.2007.08.030. [DOI] [PubMed] [Google Scholar]